TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.
Abstract
Sequence variations in the triggering receptor expressed on myeloid cells 2 (TREM2) have been linked to an increased risk for neurodegenerative disorders such as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2 variants result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing, preventing binding of lipoproteins and affecting shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of function on the microglia transcriptome. Among the differentially expressed messenger RNAs in wild-type and Trem2-/- microglia, gene clusters are identified which represent gene functions in chemotaxis, migration and mobility. Functional analyses confirm that loss of TREM2 impairs appropriate microglial responses to injury and signals that normally evoke chemotaxis on multiple levels. In an ex vivo organotypic brain slice assay, absence of TREM2 reduces the distance migrated by microglia. Moreover, migration towards defined chemo-attractants is reduced upon ablation of TREM2 and can be rescued by TREM2 re-expression. In vivo, microglia lacking TREM2 migrate less towards injected apoptotic neurons, and outgrowth of microglial processes towards sites of laser-induced focal CNS damage in the somatosensory cortex is slowed. The apparent lack of chemotactic stimulation upon depletion of TREM2 is consistent with a stable expression profile of genes characterizing the homoeostatic signature of microglia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Trem2-mediated signaling is known to inhibit the transition of microglia to a more Disease-Associated Microglia (DAM) state characterized by enhanced migration, chemotaxis, and phagocytosis [44,45].”
From TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo (2023) · cites this paper as [45]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, lack of Trem2 reduces chemotaxis and phagocytosis of microglia (54, 55).”
From Deletion of Abi3 gene locus exacerbates neuropathological features of Alzheimer’s disease in a mouse model of Aβ amyloidosis (2021) · cites this paper as [55]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microglia with TREM2 loss-of-function cannot transition to the DAM state and are locked in a homeostatic state, in which they no longer respond normally to pathological challenges [34].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“compelling evidence suggesting that TREM2 can regulate microglia phagocytic activity [44,45]”
From TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo (2023) · cites this paper as [45]
The cited source says what the claim attributes to it.
In the citing paper
“TREM2 is a cell-surface receptor of the immunoglobulin superfamily implicated in a variety of microglial functions, such as phagocytosis, chemotaxis and survival21–23.”
From PLCγ2 regulates TREM2 signalling and integrin-mediated adhesion and migration of human iPSC-derived macrophages (2021) · cites this paper as [22]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890 · cited 2×
“The migration distance was measured using Fiji [65] by drawing a line between the migrated cell and the slice culture border.”
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · cited 1×
“However, the most commonly shared pathological principle of basically all neurodegenerative diseases and many other neurological disorders is gliosis associated with an inflammatory response [4].”
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“In the WT-and Trem2-deficient offspring, we induced a focal CNS damage in the somatosensory cortex using a focussed laser beam [45 – 47] and acquired time-lapse images of the microglial response using in vivo two-photon microscopy (Fig 5A).”
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“Furthermore, for several neurodegenerative diseases, evidence exists that soluble oligomers, which may be rather stable intermediates of the aggregation process of amyloidogenic proteins, are the executers of neurotoxicity [2].”
Self-citationSynaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244 · cited 1×
“Microglia are the resident macrophages of the central nervous system and play a pivotal role in synaptic pruning and apoptotic cell clearance during development of the nervous system [51 – 56].”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547 · cited 1×
“As the innate immune cells of the brain, microglia are the first cells to respond to neuronal damage [16,41].”
The Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 1×
“Increasing evidence for a pathological role of microglia in onset and progression of neurodegenerative diseases is derived from genomewide association studies, which led to the identification of TREM2 and other microglia-related risk genes [7,11].”
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Self-citationTREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663 · cited 1×
“Onset and progression of individual neurodegenerative diseases are also driven by shared seeding and spreading mechanisms, which were originally described and thought to be specific to prion disorders [3].”
Microglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis
Sierra, A., Encinas, J. M., Deudero, J. J. P., Chancey, J. H., Enikolopov, G., Overstreet-Wadiche, L. S., Tsirka, S. E., & Maletic-Savatic, M. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.014 · Cited by 1,622 · cited 1×
“Microglia are the resident macrophages of the central nervous system and play a pivotal role in synaptic pruning and apoptotic cell clearance during development of the nervous system [51 – 56].”
A polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573
Long-term, high-resolution imaging in the mouse neocortex through a chronic cranial window
Holtmaat, A., Bonhoeffer, T., Chow, D. K., Chuckowree, J., De Paola, V., Hofer, S. B., Hübener, M., Keck, T., Knott, G., Lee, W.-C. A., et al. (2009) · Nature Protocols · doi:10.1038/nprot.2009.89 · Cited by 1,023 · cited 1×
“To image the microglia process outgrowth upon laser lesion in controlled conditions, cranial windows were implanted over the somato-sensory cortex of Iba1-GFP WT and Iba1-GFP/Trem2 / mice 14 days prior to imaging and laser lesion induction (for details, see [66]).”
Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Radde, R., Bolmont, T., Kaeser, S. A., Coomaraswamy, J., Lindau, D., Stoltze, L., Calhoun, M. E., Jäggi, F., Wolburg, H., Gengler, S., et al. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400784 · Cited by 986
Self-citationYeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C., & Sheng, M. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.015 · Cited by 943
TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151948 · Cited by 840
Yuan, P., Condello, C., Keene, C. D., Wang, Y., Bird, T. D., Paul, S. M., Luo, W., Colonna, M., Baddeley, D., & Grutzendler, J. (2016) · Neuron · doi:10.1016/j.neuron.2016.05.003 · Cited by 817
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Kleinberger, G., Yamanishi, Y., Suárez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., Struyfs, H., Pettkus, N., Wenninger-Weinzierl, A., Mazaheri, F., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009093 · Cited by 798 · cited 6×
“TREM2 is a type-1 transmembrane protein, which is shed on the cell surface [17,18].”
InfluentialSelf-citationTREMs in the immune system and beyond
Colonna, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1106 · Cited by 701 · cited 2×
“Certain mutations in TREM2 inhibit its maturation and transport to the cell surface and result in reduced phagocytosis, lipid sensing and ApoE binding, thus clearly indicating a loss of function [17,19 – 23].”
Cutting Edge: TREM-2 Attenuates Macrophage Activation
Turnbull, I. R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., & Colonna, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3520 · Cited by 688 · cited 1×
“Trem2 KO mice were kindly provided by Marco Colonna (Washington University, School of Medicine) [63].”
MethodJay, T. R., Miller, C. M., Cheng, P. J., Graham, L. C., Bemiller, S., Broihier, M. L., Xu, G., Margevicius, D., Karlo, J. C., Sousa, G. L., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142322 · Cited by 682 · cited 1×
“This is also consistent with the observation that microglia fail to cluster around amyloid plaques in the absence of Trem2 [31,60,61].”
Self-citationChiu, I. M., Morimoto, E. T. A., Goodarzi, H., Liao, J. T., O’Keeffe, S., Phatnani, H. P., Muratet, M., Carroll, M. C., Levy, S., Tavazoie, S., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.06.018 · Cited by 651 · cited 1×
“for AD and ALS, many genes typically expressed under physiological conditions such as Csf1r, Cx3cr1, Tmem119, Tgfbr1, P2ry12 or Il10ra are selectively downregulated [49,50].”
Engulfment of apoptotic cells: signals for a good meal
Ravichandran, K. S., & Lorenz, U. (2007) · Nature Reviews Immunology · doi:10.1038/nri2214 · Cited by 637 · cited 1×
“Apoptotic neurons are an important hallmark of neurodegeneration, and they are known to release “find-me” signals to attract phagocytes [42,43].”
Holtman, I. R., Raj, D. D., Miller, J. A., Schaafsma, W., Yin, Z., Brouwer, N., Wes, P. D., Möller, T., Orre, M., Kamphuis, W., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0203-5 · Cited by 619 · cited 2×
“Systems biological studies revealed a homoeostatic physiological mRNA signature [15], which is distinct from mRNA profiles of microglia in neurodegenerative diseases [48,49].”
TAM receptors regulate multiple features of microglial physiology
Fourgeaud, L., Través, P. G., Tufail, Y., Leal-Bailey, H., Lew, E. D., Burrola, P. G., Callaway, P., Zagórska, A., Rothlin, C. V., Nimmerjahn, A., et al. (2016) · Nature · doi:10.1038/nature17630 · Cited by 600
Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
Atagi, Y., Liu, C.-C., Painter, M. M., Chen, X.-F., Verbeeck, C., Zheng, H., Li, X., Rademakers, R., Kang, S. S., Xu, H., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679043 · Cited by 587
The “quad‐partite” synapse: Microglia‐synapse interactions in the developing and mature CNS
Schafer, D. P., Lehrman, E. K., & Stevens, B. (2013) · Glia · doi:10.1002/glia.22389 · Cited by 570
Sall1 is a transcriptional regulator defining microglia identity and function
Buttgereit, A., Lelios, I., Yu, X., Vrohlings, M., Krakoski, N. R., Gautier, E. L., Nishinakamura, R., Becher, B., & Greter, M. (2016) · Nature Immunology · doi:10.1038/ni.3585 · Cited by 570
Suárez‐Calvet, M., Kleinberger, G., Araque Caballero, M. Á., Brendel, M., Rominger, A., Alcolea, D., Fortea, J., Lleó, A., Blesa, R., Gispert, J. D., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506123 · Cited by 522
Self-citationCharacterizing gene sets with FuncAssociate
Berriz, G. F., King, O. D., Bryant, B., Sander, C., & Roth, F. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg363 · Cited by 473 · cited 2×
“An adjusted P -value was estimated from the result of 1 , 000 simulated null hypothesis queries according to Berriz et al [ 67 ].”
Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts
Paloneva, J., Kestilä, M., Wu, J., Salminen, A., Böhling, T., Ruotsalainen, V., Hakola, P., Bakker, A. B. H., Phillips, J. H., Pekkarinen, P., et al. (2000) · Nature Genetics · doi:10.1038/77153 · Cited by 460 · cited 1×
“A loss of function of TREM2 in disease is further supported by null mutations in TREM2 and its binding partner DAP12, which are causative for Nasu–Hakola disease [57].”
TREM2 variants: new keys to decipher Alzheimer disease pathogenesis
Colonna, M., & Wang, Y. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.7 · Cited by 418 · cited 1×
“Within the nervous system, TREM2 is predominantly expressed in microglia [14,15], the resident immune cells of the brain.”
Rayaprolu, S., Mullen, B., Baker, M., Lynch, T., Finger, E., Seeley, W. W., Hatanpaa, K. J., Lomen-Hoerth, C., Kertesz, A., Bigio, E. H., et al. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-19 · Cited by 404
Guerreiro, R. J., Lohmann, E., Brás, J. M., Gibbs, J. R., Rohrer, J. D., Gurunlian, N., Dursun, B., Bilgic, B., Hanagasi, H., Gurvit, H., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.579 · Cited by 374
Targeting mi R‐155 restores abnormal microglia and attenuates disease in SOD 1 mice
Butovsky, O., Jedrychowski, M. P., Cialic, R., Krasemann, S., Murugaiyan, G., Fanek, Z., Greco, D. J., Wu, P. M., Doykan, C. E., Kiner, O., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24304 · Cited by 358 · cited 3×
“Systems biological studies revealed a homoeostatic physiological mRNA signature [15], which is distinct from mRNA profiles of microglia in neurodegenerative diseases [48,49].”
Self-citationMouse microglial cells express a plasma membrane pore gated by extracellular ATP
Ferrari, D., Villalba, M., Chiozzi, P., Falzoni, S., Ricciardi-Castagnoli, P., & Di Virgilio, F. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.4.1531 · Cited by 352 · cited 2×
“We therefore tested whether inhibition of Syk activation in the N9 microglia cell line [39] might affect their response to chemokines in a transwell assay.”
Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
Piccio, L., Deming, Y., Del-Águila, J. L., Ghezzi, L., Holtzman, D. M., Fagan, A. M., Fenoglio, C., Galimberti, D., Borroni, B., & Cruchaga, C. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1533-5 · Cited by 337 · cited 4×
“Moreover, increased levels of CSF sTREM, as it is observed in early stages of AD, may reflect a protective activation response of microglia [24,27].”
InfluentialThe Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E
Bailey, C. C., DeVaux, L. B., & Farzan, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677286 · Cited by 303 · cited 2×
“Certain mutations in TREM2 inhibit its maturation and transport to the cell surface and result in reduced phagocytosis, lipid sensing and ApoE binding, thus clearly indicating a loss of function [17,19 – 23].”
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
Heslegrave, A., Heywood, W., Paterson, R., Magdalinou, N., Svensson, J., Johansson, P., Öhrfelt, A., Blennow, K., Hardy, J., Schott, J., et al. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0071-x · Cited by 303
Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
Ulrich, J. D., Finn, M. B., Wang, Y., Shen, A., Mahan, T. E., Jiang, H., Stewart, F. R., Piccio, L., Colonna, M., & Holtzman, D. M. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-20 · Cited by 302
Wunderlich, P., Glebov, K., Kemmerling, N., Tien, N. T., Neumann, H., & Walter, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517540 · Cited by 296
Suárez-Calvet, M., Araque Caballero, M. Á., Kleinberger, G., Bateman, R. J., Fagan, A. M., Morris, J. C., Levin, J., Danek, A., Ewers, M., Haass, C., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag1767 · Cited by 272
Self-citationTREM2 Variant p.R47H as a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis
Cady, J., Koval, E. D., Benitez, B. A., Zaidman, C., Jockel-Balsarotti, J., Allred, P., Baloh, R. H., Ravits, J., Simpson, E., Appel, S. H., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6237 · Cited by 262
TREM2 and Neurodegenerative Disease
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1306509 · Cited by 254
The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2
Klünemann, H. H., Ridha, B. H., Magy, L., Wherrett, J. R., Hemelsoet, D. M., Keen, R. W., De Bleecker, J. L., Rossor, M. N., Marienhagen, J., Klein, H. E., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000160304.00003.ca · Cited by 254
Games Played by Rogue Proteins in Prion Disorders and Alzheimer's Disease
Aguzzi, A., & Haass, C. (2003) · Science · doi:10.1126/science.1087348 · Cited by 225 · cited 4×
“The most obvious common denominator are insoluble deposits formed by misfolded proteins, which are usually highly expressed in affected cells or in affected areas of the central nervous system (CNS) [1].”
InfluentialSelf-citationDistinct roles for BAI1 and TIM-4 in the engulfment of dying neurons by microglia
Mazaheri, F., Breus, O., Durdu, S., Haas, P., Wittbrodt, J., Gilmour, D., & Peri, F. (2014) · Nature Communications · doi:10.1038/ncomms5046 · Cited by 201
Self-citationMedina, C. B., & Ravichandran, K. S. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.13 · Cited by 196 · cited 1×
“Apoptotic neurons are an important hallmark of neurodegeneration, and they are known to release “find-me” signals to attract phagocytes [42,43].”
Visualization of microglia in living tissues using Iba1‐EGFP transgenic mice
Hirasawa, T., Ohsawa, K., Imai, Y., Ondo, Y., Akazawa, C., Uchino, S., & Kohsaka, S. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20480 · Cited by 188 · cited 1×
“To allow in vivo imaging of process extension, we crossed WT and Trem2 / mice with mice expressing green fluorescent protein (GFP) under the control of the Iba1 promoter [44].”
TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance
Xiang, X., Werner, G., Bohrmann, B., Liesz, A., Mazaheri, F., Capell, A., Feederle, R., Knuesel, I., Kleinberger, G., & Haass, C. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606370 · Cited by 183 · cited 2×
“Next, we used a CRISPR/CAS9-modified N9 line, which completely lacks Trem2 expression [40] to address whether Trem2 loss of function affects the response to chemotactic stimuli.”
Self-citationYoung microglia restore amyloid plaque clearance of aged microglia
Daria, A., Colombo, A., Llovera, G., Hampel, H., Willem, M., Liesz, A., Haass, C., & Tahirovic, S. (2017) · The EMBO Journal · doi:10.15252/embj.201694591 · Cited by 174 · cited 2×
“Organotypic slice cultures were performed and immunostained as described by Daria et al [34].”
Self-citationHeterozygous TREM2 mutations in frontotemporal dementia
Borroni, B., Ferrari, F., Galimberti, D., Nacmias, B., Barone, C., Bagnoli, S., Fenoglio, C., Piaceri, I., Archetti, S., Bonvicini, C., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.017 · Cited by 173
Guerreiro, R., Bilgic, B., Guven, G., Brás, J., Rohrer, J., Lohmann, E., Hanagasi, H., Gurvit, H., & Emre, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.005 · Cited by 158
TREM2 Function in Alzheimer’s Disease and Neurodegeneration
Ulrich, J. D., & Holtzman, D. M. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00313 · Cited by 154 · cited 1×
“This is also consistent with the observation that microglia fail to cluster around amyloid plaques in the absence of Trem2 [31,60,61].”
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Henjum, K., Almdahl, I. S., Årskog, V., Minthon, L., Hansson, O., Fladby, T., & Nilsson, L. N. G. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0182-1 · Cited by 143 · cited 1×
“This is in line with the finding that sTREM2 increases during healthy ageing, which may reflect an increase of TREM2 function via enhanced TREM2 levels on the cell surface [24,27,59].”
Sieber, M. W., Jaenisch, N., Brehm, M., Guenther, M., Linnartz-Gerlach, B., Neumann, H., Witte, O. W., & Frahm, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052982 · Cited by 130 · cited 1×
“Literature searches pointed out that specifically, the downregulated genes Ccl2, Il1b, Tnf and Spp1 of the category cell motility (Table 1) are putative direct targets of Trem2 [20,32,33].”
Jančálek, R., Dubový, P., Svíženská, I. H., & Klusáková, I. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-11 · Cited by 122
Badie, B., Schartner, J., Klaver, J., & Vorpahl, J. (1999) · Neurosurgery · doi:10.1097/00006123-199905000-00075 · Cited by 111 · cited 1×
“To specifically investigate the migration capacity towards defined chemo-attractants, we took advantage of a transwell assays [37].”
Structure, expression pattern and biological activity of molecular complex TREM-2/DAP12
Paradowska-Gorycka, A., & Jurkowska, M. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.02.003 · Cited by 103 · cited 5×
“We therefore tested whether inhibition of Syk activation in the N9 microglia cell line [39] might affect their response to chemokines in a transwell assay.”
InfluentialHuang, W.-C., Yen, F.-C., Shie, F.-S., Pan, C.-M., Shiao, Y.-J., Yang, C.-N., Huang, F.-L., Sung, Y.-J., & Tsay, H.-J. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-28 · Cited by 64
Ma, J., Zhou, Y., Xu, J., Liu, X., Wang, Y., Deng, Y., Wang, G., Xu, W., Ren, R., Liu, X., et al. (2014) · Neurological Research · doi:10.1179/1743132814y.0000000376 · Cited by 42 · cited 1×
“Literature searches pointed out that specifically, the downregulated genes Ccl2, Il1b, Tnf and Spp1 of the category cell motility (Table 1) are putative direct targets of Trem2 [20,32,33].”
Regulation of human mesenchymal stem cell differentiation by TREM-2
Zhang, W., Huang, S. J., Huang, X., Li, J., Ye, P., Xu, J., Zheng, P.-Z., Shen, H., & Huang, J. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.06.005 · Cited by 18 · cited 1×
“Literature searches pointed out that specifically, the downregulated genes Ccl2, Il1b, Tnf and Spp1 of the category cell motility (Table 1) are putative direct targets of Trem2 [20,32,33].”
Cited by
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979
Self-citationMicroglia in Alzheimer’s disease
Hansen, D. V., Hanson, J. E., & Sheng, M. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201709069 · Cited by 1,935
“…roles in phagocytosis, clearing of immune complexes, and inhibition of complement (Khera and Das, 2009; Fonseca et al., 2016), and CLU/apoJ, which reportedly can function as an inhibitor of the terminal complement complex (Murphy et al., 1989; Tschopp et al., 1993; McDonald and Nelsestuen, 1997).”
BackgroundMicroglia states and nomenclature: A field at its crossroads
Paolicelli, R. C., Sierra, A., Stevens, B., Tremblay, M.-E., Aguzzi, A., Ajami, B., Amit, I., Audinat, E., Bechmann, I., Bennett, M., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.020 · Cited by 1,973
“85,86 From this example, the term ‘‘homeostat-ic’’ is not informative if not well defined and placed in the context of function.”
Self-citationMicroglial signatures and their role in health and disease
Butovsky, O., & Weiner, H. L. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0057-5 · Cited by 1,046
Self-citationMicroglia: Immune and non-immune functions
Borst, K., Dumas, A. A., & Prinz, M. (2021) · Immunity · doi:10.1016/j.immuni.2021.09.014 · Cited by 804
Metadata
- Authors
- Mazaheri, F., Snaidero, N., Kleinberger, G., Madore, C., Daria, A., Werner, G., Krasemann, S., Capell, A., Trümbach, D., Wurst, W., Brunner, B., Bultmann, S., Tahirovic, S., Kerschensteiner, M., Misgeld, T., Butovsky, O., & Haass, C.
- Affiliations
- German Center for Neurodegenerative Diseases (DE)
- LMU Klinikum (DE)
- Munich Cluster for Systems Neurology (DE)
- Brigham and Women's Hospital (US)
- Ludwig-Maximilians-Universität München (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Helmholtz Munich (DE)
- Center for Integrated Protein Science Munich (DE)
- Corresponding author
- Haass, Christian
- ORCID
- Venue
- The EMBO Reports
- Published
- 2017-05-08
- Volume
- 18
- Issue
- 7
- Pages
- 1186-1198
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC5494532
- OpenAlex
- W2612288104
- Cited by
- 351
- References
- 69
- Citations by year
- 2026: 37 · 2025: 34 · 2024: 39 · 2023: 35 · 2022: 40 · 2021: 41 · 2020: 44 · 2019: 34 · 2018: 36 · 2017: 10
- FWCI
- 17.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- EMBO Reports (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- DZNE Pub (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (EXC 1010, Mi 694/4‐1(SPP1710)/7‐1/8‐1)
- European Union's Seventh Framework Program (FP7/2007–2013)
- ERC (321366, 616791)
- Cure Alzheimer's
- Center for Integrated Protein Science Munich (EXC 114)
- Hans‐and‐Ilse‐Breuer Foundation
- German Science Foundation Collaborative Research Centre (870)
- Helmholtz Portfolio Theme “Supercomputing and Modeling for the Human Brain”
- NIH‐NINDS (1R01NS088137)
- NIA (1R01AG051812)
- National Multiple Sclerosis Society (5092A1)
- Amyotrophic Lateral Sclerosis Association (ALSA2087)
- Nancy Davis Foundation
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- TREM2, microglia, chemotaxis, microglial migration, neuronal injury, loss of function, microglial transcriptome, Alzheimer's disease, frontotemporal lobar degeneration, somatosensory cortex, neurodegeneration
- MeSH terms
- Loss of Function Mutation, Alzheimer Disease, Cells, Cultured, Chemotaxis, Humans, Membrane Glycoproteins, Neurons, Phagocytosis, Receptors, Immunologic, Microglia, Neurodegenerative Diseases, Gene Expression Profiling, Myeloid Cells, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.